Soo In Hwang
Oprichter bij VINCERX PHARMA, INC.
Oorsprong van het eerstegraads netwerk van Soo In Hwang
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 22 | |
Quadriga BioSciences, Inc.
Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Quadriga BioSciences, Inc. is a privately held pharmaceutical company based in an undisclosed location. The American company is focused on developing proprietary targeted cancer therapies by exploiting the biology of aggressive forms of cancer cells that over-express certain unique amino acid transporters on their cell surfaces. The company's mission is to develop safer and more effective treatments for patients with cancer. The company was founded by Bernd Jandeleit, Kerry J. Koller, and Wolf-Nicolas Fischer. Gordon Ringold has been the CEO of the company since 2015.
1
| Private Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Soo In Hwang via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Theron Pharmaceuticals, Inc.
Theron Pharmaceuticals, Inc. BiotechnologyHealth Technology Theron Pharmaceuticals, Inc. provides treatments for COPD and asthma. It is a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. The firm’s product TRN-157, a preclinical development therapy focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded by M. Venkatraman, Xiaoming Zhang and Jurg Pfister in 2008 and is headquartered in Sunnyvale, CA. | Biotechnology | Founder | |
EchoPixel, Inc.
EchoPixel, Inc. Electronic Equipment/InstrumentsElectronic Technology EchoPixel, Inc. develops medical imaging devices. It offers True 3D viewer 1.0 and True 3D medical education viewer. The firm’s products allows medical professionals to interact with patient-specific organs and tissue in an open 3D space emanating from a display, enabling doctors to immediately identify, evaluate, and dissect clinically significant structures in diagnostic, surgical planning and image guided treatment applications. The company was founded by Sergio Aguirre Valencia in 2005 and is headquartered Mountain View, CA. | Electronic Equipment/Instruments | Director/Board Member | |
Southern Methodist University
Southern Methodist University Other Consumer ServicesConsumer Services Southern Methodist University is a private university near the center of Dallas, SMU offers undergraduate, graduate, and professional programs through seven schools in the humanities and sciences, business, the performing, visual, and communication arts, engineering, education and human development, law, and theology. | College/University | Undergraduate Degree | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Undergraduate Degree | |
Athelera LLC
Athelera LLC Investment ManagersFinance Athelera LLC provides financial advisory services. The private company is based in New York, NY. The CEO of the company is Rodrigo Bitar. | Investment Managers | Corporate Officer/Principal | |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Doctorate Degree Corporate Officer/Principal | |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Oregon Health & Science University | College/University | Director/Board Member | |
University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
University of California, Santa Barbara | College/University | Graduate Degree Undergraduate Degree | |
University of Maryland | College/University | Doctorate Degree | |
The Burroughs Wellcome Fund
The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Investment Trusts/Mutual Funds | Director/Board Member | |
University of Chile | College/University | Corporate Officer/Principal | |
ARYx Therapeutics, Inc. (Delaware)
ARYx Therapeutics, Inc. (Delaware) Pharmaceuticals: MajorHealth Technology Part of ARYx Therapeutics, Inc., ARYx Therapeutics, Inc. (Delaware) discovers and develops drugs. The company is based in Dover, DE. ARYx Therapeutics, Inc. (Delaware was acquired by ARYx Therapeutics, Inc. on August 31, 2007. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MolecularMD Corp.
MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Medical/Nursing Services | Founder | |
Legal Aid Society of San Mateo County, Inc. | Director/Board Member | ||
Lake Forest Graduate School of Management | College/University | Masters Business Admin | |
Access Community Health Centers
Access Community Health Centers Medical/Nursing ServicesHealth Services Access Community Health Centers provides healthcare services. The firm offers medical, dental, pharmacy, behavioral health and patient resources. The company is headquartered in Madison, WI. | Medical/Nursing Services | Director/Board Member | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Founder | |
Roche Bioscience
Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | Drugstore Chains | Corporate Officer/Principal | |
Aurus Capital SA Administradora General de Fondos
Aurus Capital SA Administradora General de Fondos Investment ManagersFinance Aurus Capital SA Administradora General de Fondos (Aurus Capital) is an asset management firm headquartered in Vitacura, Chile. The firm was founded by Juan Carlos Délano Valenzuela and is a subsidiary of Aurus Gestión de Inversiones SpA. Aurus Capital provides investment advice to individual and institutional clients. | Investment Managers | Portfolio Manager-Equities | |
University of California | College/University | Director/Board Member Doctorate Degree | |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Founder Founder Founder | |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | Biotechnology | Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Georgetown University Law Center | College/University | Graduate Degree | |
NantCell, Inc.
NantCell, Inc. Pharmaceuticals: MajorHealth Technology NantCell, Inc. focuses on treating immunology diseases. It offers cell-based treatments at the molecular level. The firm develops molecularly designed drugs for genomics and proteomics and identify patients and their tumor signature at the granular cellular, DNA and protein levels. The company was founded by Patrick Soon-Shiong in 2014 and is headquartered in Culver City, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Algenis SpA
Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile. | Biotechnology | Director/Board Member | |
Acerta Pharma LLC | Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | ||
VYNE THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Baskin School of Engineering | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
OHSU Knight Cancer Institute | Director/Board Member | ||
IMMUNITYBIO, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Financial Conglomerates | Chief Executive Officer Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 45 |
Chili | 5 |
Nederland | 2 |
Sectoraal
Health Technology | 21 |
Consumer Services | 16 |
Commercial Services | 4 |
Finance | 4 |
Health Services | 3 |
Operationeel
Director/Board Member | 68 |
Corporate Officer/Principal | 62 |
Chief Tech/Sci/R&D Officer | 27 |
Founder | 25 |
Chief Executive Officer | 24 |
Sterkste connecties
Insiders | |
---|---|
Christopher Lowe | 25 |
Gordon Ringold | 20 |
Andrew McDonald | 19 |
Mark McCamish | 15 |
Ahmed Hamdy | 14 |
John Lee | 14 |
Alexander Seelenberger Farba | 13 |
Xiaoming Zhang | 11 |
Elsa Johnson | 10 |
Hermes Garbán | 9 |
Laura Bushnell | 9 |
Raquel Izumi | 8 |
Brian Druker | 8 |
Francisco Salva | 8 |
Ruth Stevens | 7 |
- Beurs
- Insiders
- Soo In Hwang
- Bedrijfsconnecties